🇺🇸 FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11730720

ALK5 inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725248

Evaluation of mantle cell lymphoma and methods related thereto

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725207

Serpina1 iRNA compositions and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725208

Conjugated antisense compounds and their use

Ionis Pharmaceuticals, Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725209

TMPRSS6 iRNA compositions and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725060

Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

Aptevo Research and Development LLC · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725217

Methods to enhance myocardial regeneration and/or repair

Regents of the University of Minnesota · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723864

Antimicrobial and anti-inflammatory compositions

The Board of Regents of the University of Texas System · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723873

Oral dosage form of ticagrelor and preparation method thereof

Elite Pharmaceutical Solution Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723881

Fortified CBD oil for treatment of PTSD

Bright Green Corporation · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723362

Broad-spectrum synergistic antimicrobial compositions

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723961

Maspin, maspin derivatives, and maspin mimetics for reducing ROS, inflammation, and skin a

Northwestern University · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723762

LIDAR based 3-D imaging with far-field illumination overlap

VELODYNE LIDAR, INC. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723952

Methods and compositions for treating Huntington's Disease

Sangamo Therapeutics, Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723885

Methods and compositions for interfering with extraction or conversion of a drug susceptib

Acurx Pharmaceuticals, Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723992

Method for extraction and purification of 68GA

The Board of Regents of the University of Texas System · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723900

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11724987

Compositions and methods of treating retinal disease

Aldeyra Therapeutics, Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723946

Methods for regulating transcription of multiple genes and expression of multiple targets

China Medical University · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723959

Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase p

HALOZYME, INC. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725005

Compositions and methods for inhibiting kinases

Inhibikase Therapeutics, Inc. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723887

Process to prepare treprostinil, the active ingredient in Remodulin®

United Therapeutics Corporation · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11718852

Non-liposomal systems for nucleic acid delivery

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11718655

Masked interleukin-12 polypeptides

Xilio Development, Inc. · Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted